Enoxaparin Sodium Injection
Product Images NDC 55154-3540

28 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 55154-3540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Figure A (Enoxaparin 01)

Enoxaparin Figure A (Enoxaparin 01)
An instructional illustration showing two hands removing the cap from a syringe. The syringe is held in one hand, with the needle cap being pulled off by the other hand, indicated by a double-headed arrow suggesting the direction to pull the cap away from the syringe.*
FDA Label Image

Enoxaparin-figure-b (Enoxaparin 02)

Enoxaparin-figure-b (Enoxaparin 02)
An instructional illustration showing a person administering a subcutaneous injection using a prefilled syringe, with an arrow indicating the injection site on the forearm or hand area.*
FDA Label Image

Enoxaparin Figure C (Enoxaparin 03)

Enoxaparin Figure C (Enoxaparin 03)
Instructional illustration depicting the administration of enoxaparin sodium injection subcutaneously. The image shows a hand holding a syringe angled towards a person's skin with an arrow indicating the injection direction beneath the skin surface.*
FDA Label Image

Enoxaparin Figure D (Enoxaparin 04)

Enoxaparin Figure D (Enoxaparin 04)
Illustration showing a hand holding a prefilled syringe for subcutaneous injection, demonstrating the correct finger placement and direction for administering Enoxaparin Sodium injection, 100 mg/mL.*
FDA Label Image

Enoxaparin Figure E (Enoxaparin 05)

Enoxaparin Figure E (Enoxaparin 05)
An instructional illustration showing a hand, wearing a glove, disposing a syringe into a container labeled with a biohazard symbol and the word 'BIOHAZARD'. An arrow indicates the syringe being inserted into the container's opening.*
FDA Label Image

Enoxaparin Sodium Chemical Structure (Enoxaparin 06)

Enoxaparin Sodium Chemical Structure (Enoxaparin 06)
Chemical structure diagram of Enoxaparin Sodium showing polysaccharide chains with annotations for chemical groups and chain composition percentages, detailing R1 and R2 substituents and the range of polysaccharide chain lengths.*
FDA Label Image

Figure-1 (Enoxaparin 07)

Figure-1 (Enoxaparin 07)
A forest plot chart comparing relative risk between Unfractionated Heparin (UHF) and Enoxaparin Sodium (Enox) across various patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent used, time to treatment, and use of PCI within 30 days. The chart indicates risk reduction percentages and relative risk markers, with a vertical line at relative risk 1.0 serving as the comparison baseline.*
FDA Label Image

Figure-2 (Enoxaparin 08)

Figure-2 (Enoxaparin 08)
A survival analysis chart comparing the hazard distribution function for Enoxaparin Sodium injection versus unfractionated heparin (UFH) over time to death or myocardial re-infarction in days. The main plot shows curves for each treatment over 30 days, with Enoxaparin having a lower hazard function than UFH. An inset graph extends the comparison to one year. The chart includes a log-rank test with significant p-values indicating differences between groups and a table of numbers at risk for Enoxaparin and UFH at various time points.*
FDA Label Image

Enoxaparin Parts Of Injection (Enoxaparin 09)

Enoxaparin Parts Of Injection (Enoxaparin 09)
An instructional diagram showing a syringe before and after use. The before-use syringe is labeled with parts including the plunger rod, needle, and needle cap. The after-use syringe is shown with the plunger rod and protective sleeve in place over the needle, indicating a safety feature for needle protection post-injection.*
FDA Label Image

Enoxaparin Ifu Figure A (Enoxaparin 10)

Enoxaparin Ifu Figure A (Enoxaparin 10)
An instructional illustration labeled Figure A showing items used with Enoxaparin Sodium injection. Items include one Enoxaparin syringe, one cotton ball or gauze, one alcohol wipe, one small adhesive bandage, and a sharps disposal container. Each item is labeled with arrows pointing to it for clear identification.*
FDA Label Image

Enoxaparin Ifu Figure B (Enoxaparin 11)

Enoxaparin Ifu Figure B (Enoxaparin 11)
An instructional illustration labeled Figure B showing two hands preparing a prefilled syringe or injection device. One hand holds the device, while the other hand peels away a protective adhesive backing from a part of the device, likely as part of the preparation for subcutaneous injection of Enoxaparin Sodium 100 mg/mL.*
FDA Label Image

Enoxaparin Ifu Figure C (Enoxaparin 12)

Enoxaparin Ifu Figure C (Enoxaparin 12)
Illustration labeled Figure C shows a syringe with a marked area indicating the location of the expiration date on the barrel. The syringe includes a plunger, needle cover, and markings on the barrel.*
FDA Label Image

Enoxaparin Ifu Figure D (Enoxaparin 13)

Enoxaparin Ifu Figure D (Enoxaparin 13)
Illustration labeled Figure D showing a syringe filled with a clear liquid. The syringe has a plunger and a needle cover attached.*
FDA Label Image

Enoxaparin Ifu Figure E (Enoxaparin 14)

Enoxaparin Ifu Figure E (Enoxaparin 14)
An instructional diagram labeled Figure E showing the outline of a human torso from the front and back views, highlighting areas on the sides of the abdomen. This figure likely illustrates recommended injection sites for subcutaneous administration of the drug Enoxaparin Sodium.*
FDA Label Image

Enoxaparin Ifu Figure F (Enoxaparin 15)

Enoxaparin Ifu Figure F (Enoxaparin 15)
An instructional illustration labeled 'Figure F' showing a hand placing a piece of paper or material into a container or slot. The simple line drawing focuses on the hand's position and action in relation to an opening, likely part of usage or disposal steps for the product.*
FDA Label Image

Enoxaparin Ifu Figure G (Enoxaparin 16)

Enoxaparin Ifu Figure G (Enoxaparin 16)
An instructional illustration labeled Figure G showing a hand removing or placing the protective cap on the needle of a syringe containing Enoxaparin Sodium injection, depicting the steps to prepare the prefilled syringe for subcutaneous administration.*
FDA Label Image

Enoxaparin Ifu Figure H (Enoxaparin 17)

Enoxaparin Ifu Figure H (Enoxaparin 17)
An instructional illustration labeled 'Figure H' showing a hand holding a syringe with a plunger being pushed down to set the dose. The syringe features a clear barrel with measurement markings and a downward arrow indicating the direction to press the plunger. The text 'Set your dose' appears beside the syringe.*
FDA Label Image

Enoxaparin Ifu Figure I (Enoxaparin 18)

Enoxaparin Ifu Figure I (Enoxaparin 18)
An instructional illustration labeled Figure 1 showing a hand with the thumb positioned to pinch or hold skin, likely demonstrating the technique for administering a subcutaneous injection.*
FDA Label Image

Enoxaparin Ifu Figure J (Enoxaparin 19)

Enoxaparin Ifu Figure J (Enoxaparin 19)
An instructional diagram showing the administration technique for a subcutaneous injection using a syringe. It depicts a hand holding the syringe at a 90-degree angle to the skin with the other hand pinching the injection site, illustrating proper injection angle and positioning for Enoxaparin Sodium injection.*
FDA Label Image

Enoxaparin Ifu Figure K (Enoxaparin 20)

Enoxaparin Ifu Figure K (Enoxaparin 20)
An instructional illustration showing the subcutaneous injection of Enoxaparin Sodium using a syringe. The image demonstrates the proper hand positioning and injection technique into the abdominal area, with an arrow indicating the injection direction.*
FDA Label Image

Enoxaparin Ifu Figure L (Enoxaparin 21)

Enoxaparin Ifu Figure L (Enoxaparin 21)
An instructional diagram labeled Figure L showing a hand administering a subcutaneous injection with a syringe into the lower abdomen near the waistline. The illustration highlights the correct injection technique and site for Enoxaparin Sodium injection.*
FDA Label Image

Enoxaparin Ifu Figure M (Enoxaparin 22)

Enoxaparin Ifu Figure M (Enoxaparin 22)
An instructional diagram showing a hand holding a syringe with a protective sleeve. The image indicates a clicking motion, likely to demonstrate how to secure or activate the syringe before use.*
FDA Label Image

Enoxaparin Ifu Figure N (Enoxaparin 23)

Enoxaparin Ifu Figure N (Enoxaparin 23)
An instructional illustration labeled Figure N showing a hand disposing of an Enoxaparin syringe with needle cap into a sharps disposal container. The syringe and needle cap are clearly identified by labels in the diagram.*
FDA Label Image

30mg/0.3ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 04)

30mg/0.3ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 04)
Label for Enoxaparin Sodium Injection, USP 30 mg per 0.3 mL in a package of 5 single-dose syringes with automatic safety devices for subcutaneous injection. Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. and distributed by Cardinal Health. The label includes dosage, storage instructions, warnings, and directions for use emphasizing safety system activation after injection and proper syringe disposal.*
FDA Label Image

40mg/0.4ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 03)

40mg/0.4ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 03)
Enoxaparin Sodium Injection USP 40 mg / 0.4 mL, presented as 5 prefilled syringes with automatic safety device for subcutaneous injection. The label shows dosage and administration instructions, storage conditions, warnings, manufacturer Shenzhen Techdow Pharmaceutical Co., Ltd., and distributor Cardinal Health 107, LLC, Dublin, OH.*
FDA Label Image

60mg/0.6ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 02)

60mg/0.6ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 02)
Enoxaparin Sodium Injection, USP 60 mg / 0.6 mL in a carton containing 5 single-dose syringes with automatic safety devices for subcutaneous injection. The label details dosage, storage, and usage instructions, including directions for activating the safety system. Distributed by Cardinal Health, Dublin, OH, and manufactured by Shenzhen Techbow Pharmaceutical Co., Ltd.*
FDA Label Image

80mg/0.8ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 01)

80mg/0.8ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 01)
Label for Enoxaparin Sodium Injection, USP 80 mg / 0.8 mL in single dose syringes with automatic safety device. The package contains 5 syringes of 0.8 mL each for subcutaneous injection. Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd., for Sandoz Inc., and distributed by Cardinal Health 107, LLC, Dublin, OH. The label includes storage, dosing, and safety instructions for syringe use.*
FDA Label Image

100mg/ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 00)

100mg/ml Bag Label (82c50153 58b8 4c35 8fc2 1d9b3d3ac7de 00)
Label panel for Enoxaparin Sodium Injection, USP 100 mg/mL, including packaging size (5 x 1 mL syringes) and indication for subcutaneous injection. Provides usage directions for the single-dose syringe with automatic safety device, storage conditions, warnings including non-child-resistant packaging, and manufacturing/distribution details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.